slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
131,341-131,400 of 319,975
01
The slide uses aggressive, alarmist language typical of short-seller research reports.POET Technologies Inc. (POET) · Wolfpack Research
Research note Short seller 1 hit
02
The slide uses a numbered list to document a pattern of failed strategic pivots, framing the company's current AI infrastructure focus as the latest in a series of failures.POET Technologies Inc. (POET) · Wolfpack Research
Research note Short seller Beat · The Monster1 hit
03
The slide uses a narrative structure to link historical missed revenue projections with specific instances of paid influencer marketing and suspicious trading activity by MMCAP International.POET Technologies Inc. (POET) · Wolfpack Research
Research note Short seller Beat · The Monster1 hit
04
The slide uses a strong, accusatory tone to highlight the risks of PFIC status for investors, citing specific financial figures and tax code implications.POET Technologies Inc. (POET) · Wolfpack Research
Research note Short seller Beat · The Struggle1 hit
05
The slide functions as a high-stakes warning/disclaimer regarding tax compliance and investment risk.POET Technologies Inc. (POET) · Wolfpack Research
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction1 hit
06
Page 6 of 10 of a research note, containing 27 numbered footnotes with links and financial data points.POET Technologies Inc. (POET) · Wolfpack Research
Research note Short seller 1 hit
07
The slide is entirely composed of numbered footnotes (28-44) providing context for previous analysis.POET Technologies Inc. (POET) · Wolfpack Research
Research note Short seller 1 hit
184
Uses LinkedIn Insights data and 10K filings to highlight a contradiction between company narrative and operational reality.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
185
The slide uses a red box to highlight the specific data point (Sales -60%) that contradicts the company's narrative.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
186
The slide uses a Q&A format to validate the thesis that Twist's growth is stalling.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
187
The slide uses a Q&A transcript format to validate the thesis that Twist is losing competitive momentum.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
188
The slide uses a Q&A format to frame the expert's critique of Twist's competitive position.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
189
The slide uses bolding and highlighting to emphasize negative sentiment regarding Twist's market position.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
190
The slide uses a Q&A format to present primary research findings from Scorpion Capital.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
191
The slide uses a Q&A format to present expert testimony.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
192
The slide uses a Q&A transcript format to frame Twist's pricing as unsustainable and predatory.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
193
The slide uses highlighted text to emphasize key negative sentiment regarding Twist's market position.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
194
The slide uses a Q&A format to validate the thesis that Twist is losing market share to larger incumbents.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
195
Uses expert testimony to frame the company as a commodity player in a niche market.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
196
The slide uses expert testimony to frame Twist as technologically inferior and structurally locked out of the broader NGS market.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
197
Includes direct quotes from a former employee now at a key competitor to substantiate the claim of dependency on third-party manufacturing.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
198
The slide uses an expert testimonial to undermine the growth narrative of the competitor and by extension the subject company (Twist).Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
199
Uses a historical blog post from a customer (Ginkgo) to perform a bottom-up TAM calculation that undermines the company's narrative.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
200
The slide uses a quote from a press release to contradict the narrative of 'dominant' market position by showing the actual revenue scale.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
201
Includes a quote from an ex-Twist executive and screenshots of GenScript's website to demonstrate service overlap.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
202
Uses aggressive language ('money-losing dumpster fire', 'tallest midget in the room') to frame the competitor as a threat to the subject company's moat.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
203
The slide uses screenshots of competitor websites to validate service overlap and funding news.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
204
The slide uses highlighted text to emphasize key competitive advantages (speed, delivery times).Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
205
The slide uses a Q&A format to validate the thesis that Twist faces an existential threat from new market entrants.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
206
The slide uses a Q&A format to present expert testimony.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
207
The slide uses expert testimony to frame Twist as vulnerable to both established incumbents and new, cheaper technologies.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
208
Includes a quote from an industry expert and a chart comparing sequencing costs to Moore's Law.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
209
Uses screenshots of competitor websites as evidence of their market presence and messaging.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
210
Twist Bioscience (TWST)Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
211
The slide uses screenshots of the CFO's professional profiles to cast doubt on his past experience.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
212
The slide uses a Q&A format to highlight potential governance issues regarding related-party transactions.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
213
The slide uses a screenshot of a LinkedIn profile as evidence to question the lack of SEC disclosure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
214
The slide uses a screenshot of the company website to frame a critique of their branding strategy.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
215
Uses a visual juxtaposition of a news headline and an illustration of prisoners working in an office setting.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
216
The slide uses direct quotes from news articles to build a case against the prison labor system.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
217
The slide uses direct quotes from an Arizona Central article to build a case against the company's labor practices.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
218
Uses a combination of LinkedIn, press releases, Wikipedia, and a BBC documentary to build a negative case.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
219
The slide uses red boxes to draw attention to Ever Alpha L.P. in both tables.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
220
The slide uses a direct quote from the S-1 filing to contrast the company's disclosure with the activist's interpretation of potential regulatory risk.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
221
Uses red boxes to highlight specific text in the SEC correspondence.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
222
The slide uses a narrative approach to deconstruct a corporate structure found in an SEC filing.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
223
The slide uses a combination of regulatory filing text and a registry search report to build a case of potential impropriety.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
224
The slide uses a narrative structure to connect a specific transaction to broader allegations of corporate malfeasance.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
225
Uses direct quotes from regulatory filings and news articles to establish a link between sanctioned individuals and current investment control.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
226
The slide uses a red box to highlight 'KANGMEI Group' in the press release text.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
227
The slide uses Q&A format to highlight discrepancies between official disclosures and internal reality.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
228
The slide uses a Q&A transcript format to highlight a potential governance or disclosure issue.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
229
The slide uses a Q&A format to highlight potential governance issues and lack of transparency at Twist.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
230
The slide uses a Q&A format to present testimony from an ex-employee, highlighting a potential governance issue.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
231
Uses red boxes to highlight specific entities in the source text.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
232
The slide uses screenshots of regulatory and database records to demonstrate the suspicious nature of the entity.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
233
Uses red boxes to highlight the shared address in two different source documents.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
234
The slide uses a red box to highlight Paladin Capital Group in the table.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
235
The slide uses a screenshot of a website bio with a red box highlighting the specific vague phrasing.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit
236
The slide uses a 'Pandora's Box' metaphor to frame the nominee's past as a source of hidden corruption.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 1 hit